Skip to main content

Advertisement

Log in

Association of Tumor Necrosis Factor-Alpha Gene Promoter Polymorphisms with Acute Viral Hepatitis in the Indian Population

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The key elements that determine the host response to either the self-limited or a severe fulminant form of liver disease are unclear. We have investigated the potential association of single nucleotide polymorphisms (SNPs) in the promoter region of tumor necrosis factor-alpha (TNFα) in their susceptibility to acute viral hepatitis (AVH) and fulminant hepatic failure (FHF) patients exhibiting specific viral etiology. A total of 124 individuals including 64 cases comprising 27 FHF, 37 AVH, and 60 healthy controls were recruited. SNPs at −238 (G/A), −308 (G/A), −857 (C/T), and −863 (C/A) of TNFα were detected by polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) and confirmed by direct sequencing. Serum levels of TNFα were determined at admission and death or recovery. Association between the TNFα genotype and susceptibility to FHF was not evident; however, carrier genotypes in relation to the −308 (GA/AA) and −857 (CT/TT) loci were found to be significantly (P ≤ 0.05) associated with susceptibility to AVH in relation to controls. The mean TNFα serum levels at admission were significantly higher (P < 0.001) in FHF than AVH patients, but no marked difference was observed between FHF-E (expired; n = 17) and FHF-S (survivors; n = 10), though the former were comparatively higher. This study suggests that SNPs at −308 and −857 of the TNFα promoter may represent an increased risk for the development of AVH but not for FHF in the Indian population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sallie R, Silva AE, Purdy M, et al. Hepatitis C and E in non-A non-B fulminant hepatic failure: a polymerase chain reaction and serological study. J Hepatol. 1994;20(5):580–588. doi:10.1016/S0168-8278(05)80343-5.

    Article  CAS  PubMed  Google Scholar 

  2. Lidofsky SD, Bass NM, Prager MC, et al. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology. 1992;16(1):1–7. doi:10.1002/hep.1840160102.

    Article  CAS  PubMed  Google Scholar 

  3. Vickers C, Neuberger J, Buckels J, et al. Transplantation of the liver in adults and children with fulminant hepatic failure. J Hepatol. 1988;7(2):143–150. doi:10.1016/S0168-8278(88)80475-6.

    Article  CAS  PubMed  Google Scholar 

  4. Ostapowicz G, Fontana RJ, Schiodt FV, et al; U.S. Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137(12):947–954.

    PubMed  Google Scholar 

  5. Schiodt FV, Atillasoy E, Shakil AO, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg. 1999;5(1):29–34. doi:10.1002/lt.500050102.

    Article  CAS  PubMed  Google Scholar 

  6. Acharya SK, Dasarathy S, Kumer TL, et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology. 1996;23(6):1448–1455. doi:10.1002/hep.510230622.

    Article  CAS  PubMed  Google Scholar 

  7. Dhiman RK, Seth AK, Jain S, et al. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig Dis Sci. 1998;43(6):1311–1316. doi:10.1023/A:1018876328561.

    Article  CAS  PubMed  Google Scholar 

  8. Kar P, Budhiraja S, Narang A, et al. Etiology of sporadic acute and fulminant non-A, non-B viral hepatitis in north India. Indian J Gastroenterol. 1997;16(2):43–45.

    CAS  PubMed  Google Scholar 

  9. Acharya SK, Panda SK, Saxena A, et al. Acute hepatic failure in India: a perspective from the East. J Gastroenterol Hepatol. 2000;15(5):473–479. doi:10.1046/j.1440-1746.2000.02073.x.

    Article  CAS  PubMed  Google Scholar 

  10. de la Mata M, Meager A, Rolando N, et al. Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection. Clin Exp Immunol. 1990;82(3):479–484.

    Article  PubMed  Google Scholar 

  11. Sekiyama KD, Yoshiba M, Thomson AW. Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol. 1994;98(1):71–77.

    CAS  PubMed  Google Scholar 

  12. Wilson AG, de Vries N, Pociot F, et al. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med. 1993;177(2):557–560. doi:10.1084/jem.177.2.557.

    Article  CAS  PubMed  Google Scholar 

  13. Stüber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med. 1996;24:381–384. doi:10.1097/00003246-199603000-00004.

    Article  PubMed  Google Scholar 

  14. Cookson S, Constantini PK, Clare M, et al. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology. 1999;30(4):851–856. doi:10.1002/hep.510300412.

    Article  CAS  PubMed  Google Scholar 

  15. Ho SY, Wang YJ, Chen HL, et al. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the −308 tumor necrosis factor-alpha promoter gene. Cancer Causes Control. 2004;15(7):657–663. doi:10.1023/B:CACO.0000036173.99930.75.

    Article  PubMed  Google Scholar 

  16. Grove J, Daly AK, Bassendine MF, et al. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology. 1997;26(1):143–146. doi:10.1002/hep.510260119.

    Article  CAS  PubMed  Google Scholar 

  17. Kim YJ, Lee HS, Yoon JH, et al. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet. 2003;12(19):2541–2546. doi:10.1093/hmg/ddg262.

    Article  CAS  PubMed  Google Scholar 

  18. Li HQ, Li Z, Liu Y, et al. Association of polymorphism of tumor necrosis factor-alpha gene promoter region with outcome of hepatitis B virus infection. World J Gastroenterol. 2005;11(33):5213–5217.

    CAS  PubMed  Google Scholar 

  19. Lu LP, Li XW, Liu Y, et al. Association of −238G/A polymorphism of tumor necrosis factor-alpha gene promoter region with outcomes of hepatitis B virus infection in Chinese Han population. World J Gastroenterol. 2004;10(12):1810–1814.

    CAS  PubMed  Google Scholar 

  20. Xu XW, Lu MH, Tan DM. Association between tumour necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection. Clin Microbiol Infect. 2005;11(1):52–56. doi:10.1111/j.1469-0691.2004.01029.x.

    Article  CAS  PubMed  Google Scholar 

  21. Heesen M, Kunz D, Wessiepe M, et al. Rapid genotyping for tumor necrosis factor-alpha (TNF-alpha) −863C/A promoter polymorphism that determines TNF-alpha response. Clin Chem. 2004;50(1):226–228. doi:10.1373/clinchem.2003.022962.

    Article  CAS  PubMed  Google Scholar 

  22. Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis. 1970;3:282–298.

    CAS  PubMed  Google Scholar 

  23. Smedile A, Farci P, Verme G, et al. Influence of delta infection on severity of Hepatitis B. Lancet. 1982;2:945–947. doi:10.1016/S0140-6736(82)90156-8.

    Article  CAS  PubMed  Google Scholar 

  24. Sambrook J, Fritsch E, Maniatis T. Molecular cloning: A laboratory manual. 2nd ed. USA: Cold Spring Harbor Laboratory Press; 1989.

    Google Scholar 

  25. Kohaar I, Thakur N, Salhan S, et al. TNFα–308G/A polymorphism as a risk factor for HPV associated cervical cancer in Indian population. Cell Oncol. 2007;29(3):249–256.

    CAS  PubMed  Google Scholar 

  26. Skoog T, Eriksson P, Hoffstedt J, et al. Tumour necrosis factor-alpha (TNF-alpha) polymorphisms −857C/A and −863C/A are associated with TNF-alpha secretion from human adipose tissue. Diabetologia. 2001;44(5):654–655. doi:10.1007/s001250051673.

    Article  CAS  PubMed  Google Scholar 

  27. O’Grady JG, Alexander GJM, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–445.

    PubMed  Google Scholar 

  28. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis. 1986;6:97–106. doi:10.1055/s-2008-1040593.

    Article  CAS  PubMed  Google Scholar 

  29. Singhal S, Kohaar I, Bharadwaj M, et al. Fas and TNF-alpha mediated apoptosis and TNF-alpha gene polymorphism in fulminant hepatic failure and its clinical relevance. Am J Gastroenterol. 2006;101(9):s151–s323.

    Google Scholar 

  30. Wilson AG, di Giovine FS, Duff GW. Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases. J Inflamm. 1995;45(1):1–12.

    CAS  PubMed  Google Scholar 

  31. Takakura M, Tokushige K, Matsushita N, et al. Possible involvement of cytokine gene polymorphisms in fulminant hepatitis. J Gastroenterol Hepatol. 2007;22:1271–1277. doi:10.1111/j.1440-1746.2007.04846.x.

    Article  CAS  PubMed  Google Scholar 

  32. Bathgate AJ, Pravica V, Perrey C, et al. Polymorphisms in tumour necrosis factor alpha, interleukin-10 and transforming growth factor beta1 genes and end-stage liver disease. Eur J Gastroenterol Hepatol. 2000;12(12):1329–1333. doi:10.1097/00042737-200012120-00011.

    Article  CAS  PubMed  Google Scholar 

  33. Tsuchiya N, Tokushige K, Yamaguchi N, et al. Influence of TNF gene polymorphism in patients with acute and fulminant hepatitis. J Gastroenterol. 2004;39(9):859–866. doi:10.1007/s00535-004-1402-1.

    Article  PubMed  Google Scholar 

  34. Tsai EY, Yie J, Thanos D, Goldfeld AE. Cell-type-specific regulation of the human tumor necrosis factor alpha gene in B cells and T cells by NFATp and ATF-2/JUN. Mol Cell Biol. 1996;16:5232–5244.

    CAS  PubMed  Google Scholar 

  35. Perneger TV. What’s wrong with Bonferroni adjustments? BMJ. 1998;316(7139):1236–1238.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The study was supported by internal funding at the study centers. There are no conflicts of interest with any of the authors. The study has been presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course, Las Vegas, Nevada, October 2006. The manuscript has not been submitted or accepted elsewhere. All authors have contributed to, seen, and approved the final, submitted version of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Premashis Kar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Singhal, S., Kohaar, I., Bharadwaj, M. et al. Association of Tumor Necrosis Factor-Alpha Gene Promoter Polymorphisms with Acute Viral Hepatitis in the Indian Population. Dig Dis Sci 55, 1106–1112 (2010). https://doi.org/10.1007/s10620-009-0799-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-009-0799-z

Keywords

Navigation